Weider’s Schiff Brand Hit By Escalating Raw Material Costs
This article was originally published in The Tan Sheet
Executive Summary
Weider's joint care franchise continues to be negatively impacted by high spending on raw materials glucosamine and chondroitin
You may also be interested in...
Weider divests Haleko
Weider Nutrition will sell its European subsidiary Haleko to Croatian holding company Atlantic Grupa, the firm announces June 17. Weider will receive roughly $15 mil. in exchange for the capital stock and partnership interests of Haleko's international subsidiaries, the firm adds. Haleko produces and markets brands such as Multipower and Multaben sports nutrition products. The sale allows Weider to focus on its core supplement business, specifically the Schiff Move Free line, with new product initiatives and acquisitions to complement its existing brands, the firm states. Sub-par performance by certain Haleko brands contributed to a 2% reduction in Weider's third-quarter sales and a 53% decline in earnings, the firm noted in April (1"The Tan Sheet" April 11, 2005, p. 18)...
Follow The Weider: Analysts Glance Askance At Weider Brand Sale
Weider Nutrition International's sale of its namesake branded nutritionals to the company's majority stockholder is raising some concerns in the investment community
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC